Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides.
about
Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis.NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathwayMechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.Inflammatory bowel disease: clinical aspects and treatments.Temporal colonic gene expression profiling in the recurrent colitis model identifies early and chronic inflammatory processes.The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis.Alleviated mucosal and neuronal damage in a rat model of Crohn's disease.Cytokine-induced alterations of α7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis.Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.The Effect of Polyphenols Isolated from Cynanchi wilfordii Radix with Anti-inflammatory, Antioxidant, and Anti-bacterial ActivityProtective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent.Experimental Models of Inflammatory Bowel Diseases.Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibilityNatural compound methyl protodioscin protects against intestinal inflammation through modulation of intestinal immune responses.Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.Regulation of the Stem Cell-Host Immune System Interplay Using Hydrogel Coencapsulation System with an Anti-Inflammatory Drug.NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction.Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.New drugs targeting Th2 lymphocytes in asthma.Beneficial effect of shikonin on experimental colitis induced by dextran sulfate sodium in BALB/c miceRegulation of NF-kappaB signaling by decoy oligodeoxynucleotides.Critical appraisal of the current practice in murine TNBS-induced colitis.The apolipoprotein E-mimetic peptide COG112 inhibits the inflammatory response to Citrobacter rodentium in colonic epithelial cells by preventing NF-kappaB activation.The straw that stirs the drink: insight into the pathogenesis of inflammatory bowel disease revealed through the study of microflora-induced inflammation in genetically modified mice.Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model.Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis.Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.The Anti-inflammatory Effects of Water Extract from Cordyceps militaris in Murine MacrophageDistinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis.NF-kappaB in inflammatory bowel disease.In vivo imaging of mucosal CD4+ T cells using single photon emission computed tomography in a murine model of colitisInflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets.Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitisMethanolic Extract of Asterina pectinifera inhibits LPS-Induced Inflammatory Mediators in Murine Macrophage.Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer.Nanomedical system for nucleic acid drugs created with the biodegradable nanoparticle platform.Regulation of NADPH oxidase subunit p22(phox) by NF-kB in human aortic smooth muscle cells.
P2860
Q33264524-16D864BE-B176-408F-9CCA-E7008B12A90FQ33815718-AD583B37-CD96-4961-A845-7B993F74ABFAQ33886458-46D6CC2C-0E18-4EC7-B63A-33084379115BQ34154099-1667AFA4-4452-4F77-8FF5-BEEC34654F38Q34233126-5EC7A63B-7A68-4CE7-A1EA-BD52153E9A59Q34253078-8FB594E8-9473-47E9-9A0E-C34D68314284Q34431476-AEB5B1B9-E4D2-4CCE-B8EF-DF17BE8C66E5Q34505311-3AB9D2E0-2352-44FE-AF68-E2B450602A4CQ34537041-9615226A-FBE5-4E57-9F8B-2C84D1CF6496Q34589792-6DA86D26-35EE-402E-A719-4A08DB800DC1Q34662156-8D0F87E8-F572-41C3-80F7-3548ED450A5AQ34876594-E9A15965-3712-4CEB-B73F-8EA25795689DQ35127476-75543594-5A16-457D-94D9-5E08D602944AQ35593759-0520CE45-1EB5-41F2-A29B-0FA460C9B032Q35618798-9D0FC0EE-8F98-4F59-AC0A-5F4E35CF616EQ35641138-73004A75-F11A-4EA4-B385-358A6D26C23BQ35664929-CEDC3C34-2D60-4DC5-A494-40C4464EF3B8Q35761406-D079CE5B-659B-43AF-AA2B-41C412053B64Q35774231-4BA1DB87-DA95-4F7B-9942-87B984650786Q36259779-A425400E-BA24-424C-863E-98BF3BA4DFB9Q36330867-4D625ADA-2D3C-4453-8AC4-FA72B850C3EEQ36485165-3A28194E-3503-432C-9D04-0EDA90C189E7Q36546684-E51BB81E-E85B-46A6-9DDF-0BCE432E3057Q36573247-4769970D-2CA3-4394-8398-D12AFBBDFF8FQ36609213-B3B43495-9782-48D5-8986-163567E5F8F4Q36711167-0FD20F14-34A0-4DBD-B918-18DB15ACE29BQ36715471-05E59B37-7227-4B58-A594-078118AE7A60Q36899424-EF3B36A5-26DD-4BDB-A4FE-98665C9F9755Q36905414-41AB27A1-B0BC-44DA-A582-E877BC47BC2CQ37076376-458E64F6-EC46-4B2D-BE3A-9461CAD55296Q37090375-908E7A88-DBAC-4A47-B5F0-00384C4A20B1Q37098695-8EC458C9-8777-4A3F-AE1F-57813CA79C33Q37163422-EE3987BA-4D62-4F49-A96E-BF885093F276Q37195230-8C6A1334-DEBC-455C-A0A0-3544679A4CD9Q37258771-46BCB74A-2395-48A0-9CC9-F99C65C6A9AEQ37308981-908D6A7B-58AB-4204-8057-DAAD0F7EBEA7Q37326536-004B1E3C-64E9-4200-B485-0EF73A06796AQ37515656-E37DE01F-F145-4247-A730-44AF5FE32509Q37950418-9230539E-FE07-490E-83F5-D770CDF8496EQ38294991-D61E3886-32FF-432C-B393-C6C62FC21B7D
P2860
Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Treatment of murine Th1- and T ...... appa B decoy oligonucleotides.
@ast
Treatment of murine Th1- and T ...... appa B decoy oligonucleotides.
@en
Treatment of murine Th1- and T ...... appa B decoy oligonucleotides.
@nl
type
label
Treatment of murine Th1- and T ...... appa B decoy oligonucleotides.
@ast
Treatment of murine Th1- and T ...... appa B decoy oligonucleotides.
@en
Treatment of murine Th1- and T ...... appa B decoy oligonucleotides.
@nl
prefLabel
Treatment of murine Th1- and T ...... appa B decoy oligonucleotides.
@ast
Treatment of murine Th1- and T ...... appa B decoy oligonucleotides.
@en
Treatment of murine Th1- and T ...... appa B decoy oligonucleotides.
@nl
P2093
P2860
P356
P1476
Treatment of murine Th1- and T ...... appa B decoy oligonucleotides.
@en
P2093
Atsushi Kitani
Ivan J Fuss
Jan C Preiss
Stefan Fichtner-Feigl
Warren Strober
P2860
P304
P356
10.1172/JCI24792
P407
P577
2005-10-20T00:00:00Z